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Abstract: The adaptation of standard integrated circuit (IC) technology as a transducer in 
cell-based  biosensors  in  drug  discovery  pharmacology,  neural  interface  systems  and 
electrophysiology requires electrodes that are electrochemically stable, biocompatible and 
affordable.  Unfortunately,  the  ubiquitous  Complementary  Metal  Oxide  Semiconductor 
(CMOS) IC technology does not meet the first of these requirements. For devices intended 
only for research, modification of CMOS by post-processing using cleanroom facilities has 
been  achieved.  However,  to  enable  adoption  of  CMOS  as  a  basis  for  commercial 
biosensors, the economies of scale of CMOS fabrication must be maintained by using only 
low-cost post-processing techniques. This review highlights the methodologies employed 
in  cell-based  biosensor  design  where  CMOS-based  integrated  circuits  (ICs)  form  an 
integral part of the transducer system. Particular emphasis will be placed on the application 
of  multi-electrode  arrays  for  in  vitro  neuroscience  applications.  Identifying  suitable  IC 
packaging  methods  presents  further  significant  challenges  when  considering  specific 
applications.  The  various  challenges  and  difficulties  are  reviewed  and  some  potential 
solutions are presented. 
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1. Introduction 
 
The definition of a ‘biosensor’ as stated by the IUPAC ius ‘a device that uses specific biochemical 
reactions mediated by isolated enzvmes, immunosystems, tissues, orcranelles or whole cells to detect 
chemical compounds usually by electrical, thermal or optical signals.’ [1]. The progress and success 
of  biosensor  development  therefore  requires  a  highly  multi-disciplinary  approach  and  a  single 
application  may  require  leading-edge  contributions  from  neuroscientists,  biologists,  semiconductor 
engineers, electronic hardware designers, pharmacologists and surgeons. 
Furthermore, most functional sensors consist of two parts: first a biological receptor or bioreceptor 
that detects the presence of the substance under test (the analyte) and, secondly, a transducer that 
detects  a response  of  the bioreceptor  to the  analyte and translates this into an output signal. The 
sensing bioreceptor is usually immobilised on the chemical/physical transducer either by some natural 
adhesion processes or by coating the surface [2]. The bioreceptor typically comprises either cells, 
DNA, enzymes or antibodies, as illustrated in Figure 1.  
 
Figure 1. Elements of a biosensor. Various biological elements may form the bioreceptor 
which are immobilised on the transducer (adapted from [3]). 
 
 
 
Transducers  can  broadly  be  classified  into  three  groups,  namely  optical,  electrochemical  and  
mass-based detection methods. Of most interest in this review are the electrochemical techniques that 
are more relevant to integrated circuit (IC)-based biosensors and the packaging technologies that form 
an integral part of such a device. Figure 2 provides an analysis of the relevant biosensor literature 
containing the terms ‘CMOS’ or ‘integrated circuit’. It is clear that cell-based types are the most 
popular in practice. This fact together with the authors’ specific interest in IC-based biosensors led to 
the choice of this as the main subject of this review.  Sensors 2011, 11                                       
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Figure 2. Analysis of the biosensor literature containing the terms ‘CMOS’ or ‘integrated 
circuit’, (data source: ISI Web of Knowledge and Google Scholar, 3rd
 February 2010). 
 
 
 
One  of  the  earliest  publications  to  define  and  discuss  biosensors  was  ‘Biomedical  Telemetry’  
in 1965 [4]. At this time, ICs were in their infancy and a patent for a Complementary Metal Oxide 
Semiconductor (CMOS) had only recently been granted [5]. Subsequently, this technology has become 
the  undoubted  foundation  of  modern  electronics  and  now  dominates  the  worldwide  IC  market. 
Economies  of  scale  have  made  CMOS  very  cheap  and  easily  available  and  perhaps,  therefore, 
naturally  attractive  to  the  designers  of  many  types  of  biosensors.  However,  due  to  the  specific 
materials  available  in  a  CMOS  process  (specifically  aluminium  and  its  oxide),  the  use  of  this 
technology to form a transducer raises the problem of the analyte/electrode interface and potential 
issues of neurotoxicity [6]. This is generally considered to be the main roadblock to CMOS biosensor 
commercialisation at present. In fact, it can be argued that CMOS technology has not yet penetrated 
the commercial market for these devices. Consider, for example, the use of multiple electrode arrays 
(MEAs, The term ‘micro-electrode array’ refers to the same technology and is similarly abbreviated to 
MEA) for in vitro neuronal recordings. The MEA represent the transducer element described above. A 
MEA becomes a biosensor if a bioreceptor is attached to the MEA and acts as a sensing element. 
MEAs have  been  developed  as a  transducer for direct interfacing with brain slices or dissociated 
neurons. Commercial MEAs are passive components that are custom-fabricated, expensive, have short 
lifetimes and have no ability to process the recorded signals. Because of these shortcomings, analysis 
of  the  literature  confirms  there  is  significant  interest  in  making  the  electrode  more  intelligent  by 
marrying integrated circuit technology with cell-based biosensors, which logically leads to the use of 
CMOS in this application. 
In summary, this review will initially cover the field in a general manner before focusing on CMOS 
MEAs for in vitro neuroscience applications. The material is structured as follows. Section 2 provides 
an overview of transducers as applied to biosensors in general, before refining the discussion to CMOS 
types  with  particular  reference  to  manufacturability.  Section  3  presents  an  overview  of  CMOS 
technology. Section 4 discusses the important role of the metal surface and metal-solution interface Sensors 2011, 11                                       
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which are of general interest to researchers interested in the use of CMOS transducer elements in 
biosensor applications. Section 5 reviews a most demanding application, namely neuronal interfaces 
and details some practical aspects required for successful neuronal recordings. Section 6 reviews the 
all-important area of packaging technology and Section 7 discusses obstacles to commercialisation. 
The review concludes with an overview of likely further work in this field. 
 
2. Transducers 
 
As  already  noted,  transducers  can  broadly  be  classified  into  three  groups,  based  on  optical, 
electrochemical  and  mass-based  detection  methods.  Of  most  interest  in  this  review  are  the 
electrochemical techniques that are more relevant to IC-based biosensors. Amperometric transduction [7] 
is  a  current-measuring  sensor  using  two  electrodes,  operated  at  constant  potential  and  is  highly 
sensitive to the concentrate of an analyte. Conductometric transducers operate in a similar manner by 
detecting changes in the electrical conductance of an analyte [8]. Similarly, potentiometric detection 
comprises a measure of electric potential at zero current (known as the ‘open circuit potential’ or OCP) 
and varies logarithmically with analyte concentration, thereby allowing the detection of very small 
changes in concentration [9]. However, it may be noted that the distinction between amperometric, 
conductometric  and  potentiometric  methods  is  largely  historical  [10]  and  all  approaches  can  be 
integrated  using  CMOS  circuits  adjacent  to  the  transducer.  An  extension  of  these  methods  is  the  
light-addressable potentiometric sensor (LAPS) which detects changes in the junction potential of a 
doped silicon layer when subjected to a photocurrent produced from an external light source [11,12]. 
An impedimetric (impedance) transducer is another form of electrochemical sensor that can be used in 
the  label-free  measurement  of  viable  cells  [13].  Piezoelectric  materials  can  be  used  as  resonance  
mass-based  transducers  by  detecting  the  additional  mass  of  chemicals  binding  to  the  surface,  for 
example coated with an antibody or other bioreceptor [14]. The frequency of piezoelectric crystal 
oscillation  varies  with  applied  mass  which  can  then  be  detected  electrically  (Quartz  Crystal 
Microbalance—QCM,  Surface  Acoustic  Wave—SAW).  Lastly,  biosensor  transducers  using  the 
magnetoelastic properties of ferromagnetic materials can also be used to detect changes in mass when 
they are used as resonating micro-cantilevers [15].  
 
2.1. Transducer Suitability for CMOS Manufacture 
 
Confirmation  that  the  electrode  interface  is  the  main  roadblock  to  CMOS  biosensor 
commercialisation at present, has been corroborated in [16], where they state: 
‘The primary design challenge using CMOS technology is the interface design between assay 
and integrated chip (IC) which generally calls for additional post-fabrication steps to facilitate 
compatibility in detecting targets (e.g., analytes).’ 
Constructing an overall picture of biosensor research is impeded by the large quantity of published 
articles and patents combined with the diversity of the technologies and applications. However, a 
quantitative analysis of the literature shows the most commonly reported IC-based biosensors use cells 
as bioreceptors with optical fibre or piezoelectric transducers. The fibre optic element is not a true Sensors 2011, 11                                       
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transducer in its own right since its role is more accurately described as a conduit to a transducer that 
is remote from the bioreceptor and analyte [17]; these remote sensors can use various spectroscopic 
techniques  such  as  absorption,  fluorescence,  phosphorescence  and  surface  plasmon  resonance. 
Additionally, cell-based biosensors using piezoelectric, magnetoelastic or optical-based transducers 
[Raman, FTIR (Fourier Transform Infrared Spectroscopy), SPR (Surface Plasmon Resonance)] are not 
readily implemented in standard CMOS integrated circuits and therefore lie beyond the scope of this 
review.  Conversely,  electrochemical  (amperometric,  potentiometric,  conductometric,  impedimetric) 
transducers are most suited to manufacture using standard CMOS processes since electrodes in contact 
with an analyte can be readily formed on the surface of the integrated circuit (the formation of CMOS 
electrodes is discussed later in Section 4.3). These electrodes may be used in conjunction with the 
various types of bioreceptor discussed above. 
The use of complex IC technology in a biosensor application naturally needs justification. Where, 
for example, a passive device is called for, requiring no transistors and where a single layer can define 
both the tracks and the electrodes, then this may often be achieved cost-effectively using a custom 
manufacturing process employing simple photolithographic methods. However, when a specification 
calls for circuitry close to the electrodes, such as low noise pre-amplifiers for neuronal recordings, the 
benefits of using CMOS are obvious. Research on biosensors using CMOS presently utilise mature 
fabrication processes, with the ability to define features of only ~0.1 μm or larger. However, the 
industry is currently working toward features as small as 22 nm for 2011 [18]. The economies of scale 
resulting from volume manufacturing and the ability to pack data processing capabilities into very 
small areas of silicon chip enable multi-electrode arrays (i.e., the transducer element) with excellent 
spatial resolution to be manufactured. These advantages are also combined with a much lower device 
cost than can be achieved using a custom semiconductor manufacturing process. 
 
3. An Overview of CMOS Technology 
 
CMOS is currently the dominant technology used worldwide in IC products; see Table 1 for a list 
of  foundries.  It  is  therefore  of  no  surprise  that  research  has  attempted  to  adapt  CMOS  for  other 
applications such as in biosensors. CMOS processes have always been purposely developed to be 
closed  to  the  surrounding  environment  to  avoid  contamination  problems  that  lead  to  low 
manufacturing yield and poor reliability. Therefore opening the chip surface to form a transducer is 
somewhat inconsistent with the goals of most semiconductor manufacturers. 
The general structure of a CMOS IC is shown in Figure 3. A single metal layer is shown in this 
generic example. The transistors are formed within the silicon substrate and the transistor gates are 
formed  above  the  field  effect  transistor  (FET)  channel  regions.  The  first  layer  of  metal  is  then 
deposited, forming contacts with the transistor source and drain regions. An interlayer dielectric (ILD) 
is deposited onto the metal to insulate the conducting layers from each other. Additional metal layers 
can therefore be deposited; each one insulated from the layers below using additional ILD layers. 
Windows in the ILD layers allow connection (vias) between adjacent metal layers.  Sensors 2011, 11                                       
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Table  1.  Major  worldwide  foundries  (for  digital  and  analogue  ICs).  The  list  includes 
companies that manufacture primarily their own IC designs (known as ‘integrated device 
manufacturers’) and ‘dedicated foundries’ that manufacture for fabless companies. 
Analog Devices 
Atmel 
AMS 
Chartered Semiconductor (Chartered) 
Elpida 
Fairchild 
Freescale 
Fujitsu 
Global Foundries  
Grace Semiconductor, China 
HHNEC (NEC) 
Hynix 
IBM 
IMEC 
Numonyx (now Micron) 
Infineon 
Intel 
International Rectifier  
Matsushita/Panasonic 
Microchip 
Micron 
Mitsumi 
National Semi 
NXP (formerly part of Philips) 
ON Semiconductor  
Powerchip 
ProMOS 
Qimonda (formerly part of Infineon) 
Renesas (formerly NEC Electronics America)  
ROHM (OKI Semiconductor) 
Samsung 
Sanyo Semiconductor (USA) Corp. 
Semiconductor Manufacturing International Corporation (SMIC) 
Sony 
Spansion 
STMicroelectronics (STMicro) 
Taiwan Semiconductor Manufacturing Company (TSMC) 
TECH Semiconductor (TECH Semi) 
Texas Instruments (TI) 
Toshiba 
TowerJazz Semicondcutor 
United Microelectronics Corporation (UMC) 
Vangaurd International Semiconductor  Sensors 2011, 11                                       
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Figure  3.  Typical  CMOS  metallisation  (simplified,  and  for  brevity  showing  only  
single-layer  metal).  The  thickness  of  the  marked  ‘stack’  is  typically  1  μm  and  here 
comprises  a  titanium  barrier  layer,  an  alloy  of  Al-Si-Cu  and  a  titanium  nitride  
anti-reflective coating. 
 
Finally, a film of insulator, often comprising two separate layers, is deposited over the chip which 
provides passivation and protects the circuits from physical damage and from external contaminants. 
The only standard openings in the passivation are onto bondpads formed from the top layer of metal. 
The bondpads provide electrical connections to/from the chip. Similar openings can also be used to 
form metal electrodes functioning as transducers. The section shown in Figure 3 has only one metal 
layer, but modern CMOS processes may have six or more such layers. The processing of the various 
layers requires flattening of the surface between each metal deposition: these are called ‘planarised’ 
processes  and  avoid  problems  of  metal  and  insulator  coverage  (‘step  coverage’).  The  result  of 
planarisation is that the chip surface is flat, with steps only at the openings of the bondpads. The height 
variation of passivation in the unplanarised processes may be several microns and therefore might be a 
consideration in the positioning of cells on surfaces of CMOS transducers [19].  
Aluminium forms the conventional basis for high volume IC metallisation and is likely to continue 
to be the material of choice for the foreseeable future (for the final metal layer in a fabrication process, 
either as standard or as a process option). A typical metallisation stack is shown in Figure 3. The 
inclusion of a small proportion of copper (typically 0.5% and up to 4%) reduces the reliability problem 
of electromigration [20,21]. Due to the presence of shallow silicon junctions at contacts (where metal 
contacts silicon) it is also necessary to prevent ‘contact spiking’; namely the eutectic alloying of the 
aluminium and silicon. This is frequently achieved through the incorporation of a ‘barrier layer’ at the 
base of the metal stack and by alloying the aluminium with silicon—typically 1 to 2 wt%. Typical 
materials for barrier layers are titanium, titanium nitride and titanium-tungsten [21]. Additionally, it is 
frequently  necessary  to  include  an  anti-reflective  coating  (ARC)  on  top  of  the  stack  to  prevent 
undesirable photolithography problems (typically titanium nitride (TiN) [21], as illustrated in Figure 3). 
Mature CMOS processes that are likely to be used for small quantity production, such as for MEAs, 
are  typically  >0.1  μm  processes  which  continue  to  use  aluminium  for  metallisation.  For  deep 
submicron (<0.1 μm) processes, the semiconductor industry has moved to the use of copper, but this Sensors 2011, 11                                       
 
4950 
may not be totally complete for niche applications until the 45 nm node is reached [22-24]. Even on 
these more advanced processes, aluminium is often used to coat the final (uppermost) metal layer to 
ensure high quality wire-bonding. 
4. Practical Aspects for Successful Neuronal Recordings 
As already noted, the design of cell-based biosensors is exceptionally multi-disciplinary. Clearly, an 
understanding  of  cell  physiology  is  a  pre-requisite  to  any  consideration  of  cell-based  biosensors. 
However a detailed overview of this material is beyond the scope of this review and can be studied in a 
variety of standard texts, e.g., [25]. Other aspects, also common to many other type of biosensor, 
include cell adhesion, the metal-solution interface and biocompatibility: each of these is described in 
some detail in the following subsections. These are also interrelated since it will be shown that a cell 
must be in intimate contact with an electrode for neuronal recordings, having changed its morphology 
from conceptually spherical and motile [motility is the ability for a cell to move (migrate) without the 
application of an external force] to flattened and adhered. The basic principles of CMOS technology 
were reviewed in the previous section. This was essential since the modification of standard CMOS is 
a  critical  current  research  topic  if  the  technology  is  to  meet  the  needs  of  a  particular  cell-based 
biosensor. This section contains a discussion of the use of CMOS MEAs for neuroscience applications. 
In this case the MEA can be a simple transducer element used to sense the action potentials of neurons 
or  can  be  part  of  a  cell-based  biosensor  if  the  neuron  is  acting  as  a  bioreceptor  (e.g.,  for  high 
throughput drug screening). 
4.1. The Aluminium Surface and Aluminium-Solution Interface 
Prior to discussing the modification of CMOS electrodes and the changes necessary to satisfy the 
requirements of a practical transducer for cell-based biosensors, it is essential to understand the metal 
surface  which  is  naturally  presented  by  aluminium  pads  to  environments  such  as  physiological 
solutions and cells. The nature of aluminium is determined by its physical and chemical characteristics 
which are fundamental to its performance as an electrode material. The environments which are of 
most interest here for cell-based biosensors are aluminium in air, water and physiological media. 
Aluminium, along with other metals used in medicine such as titanium, is very reactive—its surface 
reacts  spontaneously  with  air  to  form  a  ‘natural’  oxide  film  of  amorphous  Al2O3.  This  reactivity  
is  determined  by  the  Gibbs  free  energy  of  formation,  being  highly  negative  for  aluminium  
(−791.15 kJ∙mol
−1) and titanium (−888.8 kJ∙mol
−1) [26,27]. The instantaneous reaction with oxygen in 
air results in an oxide growth rate that is proportional to log-time: the thickness forms very quickly to 
approximately 10 nm after which it is self-passivating, preventing further reaction and film growth [28]. 
The  stability  of  the  metal  and  oxide  film  in  a  medium  is  defined  by  the  electrochemistry  of 
corrosion and is best illustrated using a Pourbaix diagram as shown in Figure 4. It is important to 
consider the pH not only of the bulk solution but also the localised conditions. The electrochemical 
potential, E, defined by the Nernst equation, will also vary due to local conditions such as alloying 
species, defects and contaminants. At low pH, aluminium dissolves to form Al
3+ ions and at high pH it 
dissolves  to  form  AlO2
−,  these  conditions  both  being  the  basis  of  corrosion.  In  deionised  water 
corrosion should not occur, but in saline physiological medium, Cl
– chloride ions will be adsorbed to Sensors 2011, 11                                       
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the surface which creates localised acidic conditions (i.e., dilute hydrochloric acid) under which the 
passivated surface deteriorates leading to corrosion of the underlying metal [29]. This process then 
accelerates (auto-catalytic) since the aluminium dissolution process causes a further increase in Cl
– 
concentration at the corrosion site. A saline physiological medium is therefore potentially damaging to 
an unprotected aluminium CMOS electrode [30]. 
Figure 4. Pourbaix diagram for aluminium. This is derived from the Nernst equation and is 
used to show the regions of thermodynamic stability for a metal/electrolyte interface as pH 
versus electrode potential, E. 
 
In addition to the stability of an aluminium surface exposed to a biological medium, it is vital to 
understand the factors that determine the electrical characteristics of such an interface. For example 
and  as  discussed  later,  the  electrical  characteristics  of electrodes for transducers  sensing neuronal 
activity are determined primarily by the chemistry of the solid-solution interface. The basis for modern 
interface models originates from the theory devised by Hermann von Helmholtz in the nineteenth 
century, later refined by Gouy and Chapman. The basic premise of the models is the existence of an 
electrical double layer at the solid-solution interface which in turn forms the basis of electrical circuit 
models of the interface. These theories are presented in [27] and [31] and will not be discussed further 
in this review. 
4.2. Biocompatibility of CMOS Electrodes 
Any CMOS electrode in contact with biological cells, tissue and/or physiological medium needs to 
be compatible with its environment, must not alter the physiology of the analyte under investigation or 
being detected and must be non-toxic to all the biological components in the system. Unfortunately, 
one  difficulty  with  assessing  biocompatibility  of  IC  materials  is  that  no  definitive  list  has  been Sensors 2011, 11                                       
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compiled [32] and therefore results must be taken from more loosely related applications such as 
orthopaedics or smaller evaluations. 
Without modification of the CMOS pads, the surface presented by nearly all CMOS technologies is 
aluminium.  The  biocompatibility  of  aluminium  and  its  oxide,  alumina,  have  been  thoroughly  
studied,  much  work  having  being  done  to  evaluate  in  vivo  performance  for  use  with  orthopaedic  
prosthetics [33,34]. The performance of aluminium also depends much on the adherent superficial 
native oxide layer (alumina) and corrosion. However, the in vivo use of alumina has generally been 
confined to orthopaedics. This is because of its poor compatibility with blood due to its thrombogenic 
action (i.e., its tendency to cause undesirable clotting). Frequently, aluminium is coated with titanium 
nitride  to  improve  in  vivo  performance  [33].  For  applications  ranging  from  prosthetics  to  CMOS 
transducers, the overall in vivo interaction with their environment is primarily governed by the natural 
chemistry of the body: simplistically, this is a NaCl aqueous solution of concentration ~0.1 M with 
organic  acids,  proteins,  enzymes,  macromolecules,  electrolytes,  dissolved  oxygen  and  nitrogenous 
compounds. The resulting pH is approximately 7.2, often decreasing to ~5.5 in the vicinity of tissue 
damage. Possible interaction mechanisms between any material, such as an electrode, and the body 
include inert/bioinert (no reaction), biodegradation (gradual breakdown by biological or biochemical 
processes), bioresorption (removal by cell activity or by continuous ionic diffusion) and bioactivity (a 
specific behaviour of a material). 
The degradation of the native oxide of aluminium (alumina) on a CMOS aluminium electrode in a 
physiological environment is limited by its natural corrosion resistance due to the metal being in its 
highest oxidation state. However, a concern is that either defects in the oxide film on an electrode may 
enable aluminium ions to leach into the body or that the alumina itself may degrade. In physiological 
conditions  aluminium  easily  forms  an  insoluble  Al(OH)3  precipitate  or  a  solution  of  AlCl3.  The 
toxicity of these and other aluminium salts (10–100 mM) has been evaluated and shown to have only a 
small effect on the viability of mammalian neuronal cells [35].Additionally, neurotoxicology research 
into  Alzheimer’s,  has  not  shown  a  causal  relationship  between  the  disease  and  aluminium  
exposure [36]. Walpole et al. [37] and Karlsson et al. [38] tested nanoporous alumina substrates for 
aluminium ion leakage and found the dissolution rate of ions into culture measured after nine days was 
sufficiently low to be considered as non-toxic. In the context of IC materials, an in vitro assessment  
in [39] showed an enhanced proliferation (vitality) of Caco2 epithelial cells on aluminium versus the 
glass controls. These results therefore suggest that aluminium with a stable native oxide may form a 
biocompatible surface as a transducer for cell-based biosensors, but only where the electrode remains 
electrochemically stable—a condition usually difficult to achieve in the context of biosensors. 
Whilst  we  are  primarily  interested  in  the  CMOS  electrodes  in  the  context  of  this  review,  the 
biocompatibility of the surrounding material must not be overlooked. CMOS ICs predominantly use 
silicon  nitride  as  the  surface  (passivation).  Receveur  et  al.  [32]  concluded  that  silicon  nitride  is 
biocompatible,  as  stated  by  references  [40-42].  In  [39]  it  was  shown  that  silicon  nitride  was  an 
excellent substrate for Caco2 cell proliferation. Sensors 2011, 11                                       
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4.3. Practical Aspects for Successful Neuronal Recordings: The CMOS-Neuron Interface 
Research  into  CMOS  interfaces  for  neuronal  recordings  has  centred  mainly  on  two  types  of 
electrode: the electrolyte-oxide-semiconductor (EOS) FET and the metal electrode. These are explored 
in subsections (a) and (b) below while section (c) describes some more recent research using porous 
alumina  based  electrodes.  It  is  maintained  that  the  composition  of  the  transducer  interface  is  the 
primary  obstacle  to  designing  successful  products;  other  aspects  of  a  CMOS  neuronal  interface 
product, such as signal amplification, data processing and communication, can leverage capabilities 
that are already well-established in the semiconductor industry. In this respect, impressive CMOS 
MEAs have already been demonstrated [43-51] and so the design of CMOS circuitry is not a focus of 
this review. 
(a) The Electrolyte-Oxide-Semiconductor (EOS) FET 
First, an EOS FET interface has been pursued by Fromherz et al. at the Max Planck Institute of 
Biochemistry, Munich, as it offers the potential of providing a first-order (direct) response to the action 
potential  (i.e.,  FET  current  is  proportional  to  membrane  potential)  [52,53].  For  commercial 
implementation, complex (lithographic) post-processing of the IC may be required to form EOS FETs 
from standard CMOS processes. This is because the CMOS gate oxide layer is below the passivation 
and all metal layers. CMOS gate oxides are therefore not readily interfaced directly to culture medium 
and  cells.  A  further  concern—little  emphasised  in  the  literature—is  the  possibility  that  such  an 
arrangement  might  be  adversely  affected  by  ionic  contamination  from  contact  with  the  culture  
medium [20]. Drifting of EOS FET voltage thresholds could conceivably be compensated for within an 
amplifier  design,  but  ionic  contamination,  being  highly  mobile,  is  just  as  likely  to  cause  rapid 
functional failures in CMOS operational amplifiers or logic gates surrounding the electrode array. This 
may ultimately limit the ability to use this form of EOS FET to produce a commercial product with a  
useful lifespan. 
An adaptation of the EOS FET has been presented in [55] and [56] which improves the passivation 
of the transistor by connecting the standard polysilicon gate of the sensing FET to the surface of the IC 
(Figure 5). The top layer of metal defines the sensor area but this is covered by standard IC passivation 
to avoid the need for post-processing. This process is reported to work well when the electrode is 
configured as an ion sensitive field effect transistor (ISFET) [55]. For cell-based sensors, sensitivity 
improvements  have  been  necessary  by  switching  the  standard,  thick  (typically  1–2  μm)  CMOS 
passivation to a hafnium high-κ dielectric passivation [57,58]. The hafnium process may re-introduce 
the  need  for  photolithography  to  open  windows  for  bondpads  and  therefore  the  cost  of  such  
post-processing  needs  consideration.  Preliminary  tests  showed  the  thin  (50  nm)  hafnium  film 
successfully passivates the aluminium pads from corrosion for short cell-based assays of five days. 
Further work is required to assess the integrity of the thin film during longer periods of use (for 
example, in-vitro cell cultures may be up to, say, 56 days [56] and electrodes may be expected to be  
re-usable). Conceivably, a thicker uniform hafnium film could be deposited over the whole device after 
wire bonding and assembly, but unfortunately hafnium deposition is a 250 °C  process under vacuum that, 
whilst compatible with devices at the wafer level, is incompatible with packaged devices (moulding 
compounds and elastomer may out-gas or fracture under high vacuum and may decompose at 250 ° C). Sensors 2011, 11                                       
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Figure 5. A floating gate EOS (Electrolyte-Oxide-Semiconductor) FET. The FET gate, G, 
is accessed from the top of the IC through the metal layers. The upper metal layer defines 
the sensitive (electrode) area which is covered by the silicon nitride passivation. Charge 
above the sensitive area induces a charge on the FET gate which in turn modulates the 
current in the n-type silicon channel between source, S, and drain, D. (From [56]). 
 
As  a  result,  it  seems  that  implementing  an  EOS  FET  in  CMOS  either  leads  to  an  ionic 
contamination hazard or requires post-processing photolithographic steps in a cleanroom to define 
bondpad windows in a hafnium passivation. Indeed the need for post-processing for these FETs has 
been confirmed in a recent review [59]: ‘With an appropriate post-process these [floating-gate FET] 
devices can be operated in a liquid environment.’ 
(b) The Use of Metal Electrodes 
An alternative approach to the EOS FET is the use of metal (usually platinum) electrodes based on 
standard CMOS bondpads (Figure 6) [45,48,60,61].  
Figure 6. Adaptation of CMOS using photolithographic processing to re-define electrodes 
using  platinum  (from  [64]).  This  process  requires  a  microfabrication  facility  to  add 
additional layers on top of the CMOS IC (and therefore does not meet a low-cost criterion). 
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However, because of the cleft between cell and substrate and the double layer at the solid-solution 
interface, this approach in fact also leads to a capacitive coupling. However, where the interface is 
particularly tight (i.e., with a small cleft between cell and substrate), models show that it may be 
possible  to  provide  a  first-order  (ohmic)  response  since  the  cleft  can  be  modelled  as  a  resistive 
component  that  sinks  an  action  potential  ion  current  laterally  under  the  cell  into  the  bulk  of  the 
electrolyte [62,63]; however achieving such a small cleft is difficult in practice. 
Interestingly, despite the difficulties with both the direct and capacitive coupling methods, there are 
some similarities in their equivalent circuits: both electrical models include a capacitive cleft and both 
recording electrodes typically connect to a high impedance FET gate. However, as established in [69], 
the sensitivity of the metal electrode still out-performs the floating gate EOS FET, with the metal 
electrode clearly more suitable for recordings from small mammalian neurons. 
(c) Porous Alumina Based Electrodes 
Previous work by the University of Bath and King’s College London was unable to obtain neuronal 
recordings using standard CMOS aluminium electrodes. The main reason for this was uncontrolled 
corrosion at the aluminium surface. Recent work has focused on demonstrating that aluminium CMOS 
microelectrodes can be made both biocompatible and effective by converting them to porous alumina. 
ICs  were  successfully  anodised  and  their  barrier  oxides  electrochemically  thinned,  resulting  in 
impedance comparable to the unmodified aluminium and other planar electrodes [65]. The alumina 
had inter-connected pores, as predicted by the earlier work using Al-Si-Cu coverslips [6]. It was shown 
that infiltrating the alumina pores with metal further reduced impedance. For applications requiring a 
planar electrode surface, gold was electrodeposited into the porous alumina to provide a bio-inert 
surface. For neuronal recording applications that often call for particularly low impedances, the planar 
gold was coated with platinum-black resulting in a further reduction in impedance to less than 40 kΩ 
(at 1 kHz) for each 30 μm diameter electrode.  
4.4. Maximising the Neuronal Recording Signal 
The  height  of  the  cleft  between  the  cell  and  electrode  is  a  key  parameter  that  influences  the 
magnitude of extracellular neuronal signals and has therefore been a primary consideration in the 
development of state of the art neuronal sensors [66]. The use of adhesion proteins has been a main 
line of investigation as a tool to minimise the cleft by forming tight electrode junctions with the 
electrode/substrate. It was concluded in [67] that the proteins promote cell adhesion and that the cleft 
can be minimised using a coating of RGD peptide sequence (RGD = arginine–glycine–aspartic acid 
(Arg-Gly-Asp)—a laminin and fibronectin fragment). In [68] it was noted that RGD immobilises cells, 
with the exception of neurons. Polylysine was also discussed as an adhesion molecule but the cleft size 
was expected to be larger compared to a layer of RGD peptide. In [63] and [69] it was stated that the 
YIGSR peptide sequence—a laminin fragment—also promotes cell adhesion whilst minimising cleft 
size  (YIGSR  =  tyrosine–isoleucine–glycine–serine–arginine).  Other  methods  to  promote  good 
adhesion include the use of polyethylenimine (PEI) and laminin [70]. Whilst generally successful at 
producing adhesion, the cleft is wider and so they produce a less efficient electrical interface (Figure 7) 
(coupled voltage reduces with the square of the cleft distance). A MEMS approach to adhesion has 
also been investigated whereby a wafer was micromachined to provide pneumatic anchoring of rat Sensors 2011, 11                                       
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cardiomyocytes [71]. This technique has been successfully incorporated into a family of single-use 
MEAs  manufactured  by  Cytocentrics  AG  (Germany)  [72].  Investigations  by  [73,74]  showed  that 
modification of a silicon surface by patterning (in the range of tens of nanometers to micrometers) can 
also assist with attachment. 
Figure 7. TEM images showing examples of cell-substrate clefts—from [75]. Cells have 
been fixed and sectioned using a focussed ion beam: (a) A platinum substrate (the surface 
marked  with  black  arrows)  was  coated  with  laminin-111  prior  to  adhesion  of  chicken 
embryo  neurons.  The  cleft  is  between  the  adhered  cell  membrane  (marked  by  white 
arrows) and the platinum surface and was measured to be 27–108 nm; (b) L1 Ig6 (the sixth 
immunoglobulin  domain  of  cell  adhesion  molecule  L1  and  known  to  promote  neurite 
extension)  has  a  lower  molecular  weight  (8  kDa)  and  is  a  smaller  molecule  than  
laminin-111 (~800 kDa). Smaller molecules generally result in smaller clefts, as illustrated 
here by the cleft of 26–79 nm. 
 
(a) 
 
(b) 
 
Silicon substrates have been successfully modified by [76] and [77] to produce porous silicon. 
Scanning  electron  microscope  (SEM)  images  suggested  a  tight  junction,  but  these  need  to  be 
confirmed by electrical characterisations. Unfortunately, the opening of windows to silicon introduces 
the same drawback as the EOS FET in that ionic contamination of the CMOS logic circuits is likely. 
A second key parameter affecting the effective signal of a neuronal recording is the impedance of 
the  electrode.  The  majority  of  publications  reporting  successful  recordings  from  CMOS  ICs  (c.f. 
references  in  Section  4.3  above)  use  a  coating  on  the  electrode  of  platinum  black  to  increase  its 
effective surface area and hence decrease its impedance. This is a well-established method used for 
electrophysiology  and  other  electrochemistry  applications  [78].  CMOS  IC  electrodes  have  been 
successfully coated with biocompatible platinum and platinum black [79]: the platinum pads were 
created by a lithographic patterning step, but the subsequent platinum black was an electrodeposition 
performed by biasing the stimulation circuitry. The platinum black was shown to reduce successfully 
the electrode impedance. Interestingly, the benefit arising here from decreased electrode impedance is 
not intuitive: the improvement comes not from an increase in signal amplitude (the signal magnitude 
relates to the proportion of an electrode that is covered by a cell, i.e., forming a potential divider. 
Decreasing the impedance per unit area using platinum black decreases the impedance under the cell Sensors 2011, 11                                       
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but also decreases the impedance to the grounded bulk electrolyte and therefore the platinum black has 
little direct effect on signal amplitude) but instead from reducing the noise produced by the electrode 
itself—i.e., the benefit is an improved signal-to-noise ratio at the FET gate input. This occurs since the 
‘root mean square’ of the instantaneous noise (r.m.s.) thermal noise (additional sources of noise exist 
in electrode-electrolyte interfaces [80] but thermal noise dominates in neuronal recording FET-based 
electrodes) , V, produced in an electrode is proportional to the root of its resistance, R, where, k is 
Boltzmann’s constant, T is temperature and B is the bandwidth [81,82] (see Equation 1): 
kTBR V 4    (1)  
Commercial MEAs used for mammalian neuronal recordings include the Multi Channel Systems 
and MED64 (Alpha Med Scientific, Inc.) products. Quality assurance data for MEAs purchased from 
Multi Channel Systems showed all electrodes had individual impedances of 39 k–41 kΩ at 1 kHz (the 
characteristic frequency of an action potential), that is in agreement with their documentation claiming 
20 k–400 kΩ for their range of titanium nitride electrodes [83]. The MED64 electrodes are claimed to 
have impedances of 7 k–10 kΩ at 1 kHz [84]. To prepare CMOS IC electrode arrays for neuronal 
recordings at the University of Bath, it was decided that the 1 MΩ impedance at 1 kHz achieved with 
the gold deposition alone was unacceptably high. The standard technique of lowering the impedance 
by coating with platinum black was used, with a target impedance of 40 kΩ (at 1 kHz) for 30 μm 
diameter electrodes. Figure 8 shows a porous alumina and gold CMOS electrode after deposition of 
platinum black.  
 
Figure 8. Porous alumina and gold CMOS electrode after deposition of platinum black  
at  50  mA∙cm
−2.  The  platinum  is  within  the  defined  pad  area  and  is  flush  with  the 
passivation surface. Scale bar is 2 μm. 
 
As outlined in Section 1, the potential applications of a silicon-electrode junction are diverse and so 
the particular type of cell being interfaced is relevant and must be taken into consideration when 
reviewing  recent  developments  in  the  literature.  For  example,  many  of  the  published  results Sensors 2011, 11                                       
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demonstrating successful recordings from electrically active cells relate not to mammalian neurons but 
to human  embryonic kidney  (HEK) cells and cardiomyocytes  [48,62,70,79,85-96]. Such cells may 
often produce signals of larger amplitude than achievable with mammalian neurons. Therefore, due to 
the  low  electrode  impedance,  cell  positioning  and  small  cleft  requirements,  producing  reliable  
extracellular  mammalian  neuron  recordings  using  CMOS  electrodes  is  probably  one  of  the  most 
demanding applications. The above review of neuronal recording serves to illustrate the complexity of 
many  CMOS  transducers  and  cell-based  biosensor  applications  where  the  neurons  serve  as  the 
bioreceptor.  
5. CMOS Neural Interfaces 
There are many areas of biomedicine that are driving developments in the stimulation and recording 
of  neuronal  electrical  activity.  Applications  are  primarily  drug  discovery  pharmacology,  neural 
interface systems, cell-based biosensors and systems to assist in the understanding of neural network 
behaviour. Techniques are available that span the scale of (spatial) resolution: whole brain imaging is 
possible  through  methods  such  as  electroencephalography  (EEG),  positron  emission  tomography 
(PET) and functional magnetic resonance imaging (fMRI) [97]. Populations and networks of neurons 
can be observed using voltage-sensitive optical dyes that provide response times (temporal resolution) 
usually  into  the  millisecond  range,  although  recent  progress  has  extended  the  resolution  into  the  
sub-millimetre range [98]. However, dyes can be toxic, the dye metabolites can be toxic, or strong 
illumination can cause photodynamic damage [99]. Single neuron recordings may be non-invasive but 
provide only very limited information from a small region of space, typically 10–50 μm [100]. As an 
extension to the methods of Hodgkin and Huxley, the patch clamp retains the benefit of excellent 
temporal  resolution,  effectively  unlimited  by  the  fast  response  times  of  electronic  measurement 
instruments. The patch clamp is therefore an excellent method for electrical stimulation and recording 
of  single  cells  but,  being  an  invasive  method  (with  the  clamp  damaging  the  cell  membrane),  the 
recording duration is usually limited to a few hours. 
It can be seen from Figure 9 that there is a lack of techniques that provide a spatial resolution 
enabling  recording  from  one  or  more  neurons  but  with  a  temporal  resolution  that  allows  action 
potential recordings (sub-millisecond) for many days. This is important for monitoring a range of 
biological  processes  in  single  neurons  or  networks  such  as  drug  tolerance,  neurotoxicity, 
neurodegradation,  network  development  and  activity,  including  learning,  memory  and  circadian 
rhythm. This gap in techniques can be filled by non-invasive extracellular electrodes, and the ability to 
lay out an array of electrodes on a surface for greater spatial coverage makes IC technology a good 
candidate for this purpose. Sensors 2011, 11                                       
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Figure 9. Map of imaging techniques on a spatial-temporal plane (adapted from [100]). 
 
5.1. The Electronic-Neuronal Interface: Commercial MEAs 
This  section  discusses  MEAs  for  neuronal  recording  and  stimulation  applications  where  the 
electrode is acting as a transducer. Although generally suffering from limited spatial resolution and 
expensive to manufacture, passive MEAs have been manufactured commercially for some time. As a 
result, as already noted, much work was begun during the 1990s in order to leverage the potential 
benefits of planar semiconductor technologies—primarily CMOS—offering a potentially cheap source 
of electrodes, integrated signal processing and increasingly excellent spatial resolution (with on-chip 
signal multiplexing and processing, large CMOS arrays may be formed with spatial resolution limited 
by the cell culture density rather than the IC technology. For example, a 128 ×  128 array of 10 μm 
diameter electrodes at 50 μm spacing would be a resolution of 4 ×  10
8 m
−2). Early investigations, 
especially by groups such as Fromherz et al. at the Max Planck Institute of Biochemistry identified the 
adherence of biological cells to the IC electrodes as a major challenge [101]. Progress has been slow as 
the factors influencing cell-substratum adhesion are complex. 
The  principal  manufacturer  of  MEAs  is  presently  Multi  Channel  Systems  (MCS)  GmbH 
(Germany), supplying a range of MEAs with planar microelectrodes, typically an array of 60 recording 
electrodes,  plus  an  optional  large  planar  stimulation  electrode  [102].  MCS  have  developed  a 
comprehensive set of amplification, data acquisition and data analysis tools to support their MEAs 
product line. MCS have identified that low impedance electrodes are necessary in order to achieve 
acceptable signal-to-noise ratios and they have therefore developed a high surface area titanium nitride 
(TiN) electrode which typically achieves an impedance of only 40 kΩ at 1 kHz for a circular electrode 
of 30 μm diameter (Figure 10). Whilst the electrodes are high performance, their durability is low: 
MCS state that the electrodes are re-usable but cleaning is difficult as the electrodes cannot be touched 
with cotton buds, etc, due to the fragility of the TiN. The electrodes also seem to degrade in ambient Sensors 2011, 11                                       
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conditions and therefore might have a useful maximum lifetime of one year. Other suppliers of passive 
MEAs  use  conventional  platinum  and  platinum  black  electrodes,  probably  due  to  their  improved 
robustness. Ayanda Biosystems SA (Switzerland), manufacture MEAs with a footprint compatible 
with the MCS data acquisition systems [103].  
 
Figure  10.  A  Multi  Channel  Systems  MEA.  The  magnified  images  show  the  array  
of 64 electrodes and further SEM images showing a single electrode and its surface. The 
lower image shows the high surface area dendritic TiN (from [102]). 
 
 
Ayanda produce square (40 ×  40 μm) platinum electrodes with typical impedances of 400–600 kΩ 
(at 1 kHz). In partnership with Bio-Logic SAS (France), Ayanda also produce passive MEAs with up 
to 256 electrodes [104]. Alpha Med Scientific, Inc.(Japan), manufacture the MED64 system which 
comprises 64 electrode MEAs and supporting data acquisition and analysis instrumentation [105]. All 
three manufacturers use glass substrates which have the benefit of allowing imaging of the cells using 
phase contrast microscopy. MEAs can be supplied optionally with indium tin oxide (ITO) tracks that 
are transparent at visible wavelengths and therefore further improve the clarity of optical microscopy. 
This is not possible with CMOS as the silicon substrate is opaque. The MED64 system uses square 
electrodes of 50 ×  50 μm coated with platinum black to achieve a low impedance of only 7–10 kΩ  
(at 1 kHz). It should be noted that this low impedance is achieved at the expense of the platinum black 
creating tall (7.39 μm) dendritic growths above the substrate surface (Figure 11). It is questionable 
whether the body (soma) of dissociated neurons will readily cover such a tall feature and instead the 
cells may prefer to adhere only to the substrate.  
A recent entrant into the MEA market is the company 3Brain [106], a spin-out of CSEM (Centre 
Suisse  d’Electronique  et  de  Microtechnique)  and  represents  a  first  for  the  penetration  of  CMOS 
technology into the MEA market.  Sensors 2011, 11                                       
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Figure 11. MED64 MEA: (a) a single 50 ×  50 μm electrode showing copious platinum 
black  deposition  used  to  achieve  a  low  impedance;  (b)  profile  of  a  MED64  electrode 
showing  tall  (7.39  μm)  dendritic  growth,  mainly  at  the  periphery  of  the  electrode  
(from [105]). 
   
(a)  (b) 
The 3Brain APSMEA chip (Figure 12) uses CMOS to form an array of 4,096 electrodes for high 
spatial resolution electrophysiology. At approximately £ 140, it appears competitively priced against 
the Multi Channel Systems passive MEA (£ 250–300 each). Each electrode is 21 m ×  21 m with a 
pitch of only 42 m. The IC includes on-chip address decoders and signal processing, and claims high 
sensitivity and low-noise [44]. Details of the CMOS post-processing and the electrode surface are 
undisclosed [44,107] and therefore a detailed appraisal of their process is not possible here. 
 
Figure 12. A CMOS-based sensor for high spatio-temporal resolution electrophysiology, 
produced by 3Brain. The device comprises an array of 4096 electrodes, each 21 m ×  21 m. 
The post-processing and electrode surface material is undisclosed (from [44]). 
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5.2. Other Commercial CMOS-Based Biosensors 
Beyond neuronal interfaces, commercial CMOS-based products are presently few. However, new 
products are emerging, but are mainly beyond the scope of this article (i.e., not cell-based), such as the 
DNA sequencing chip from Ion Torrent (now part of Life Technology Corp.) [108]. However even 
here,  the  use  of  CMOS  requires  additional  layers  to  be  deposited  on  the  top  of  the  CMOS  and 
patterned using photolithography to provide biocompatibility. Similarly, CustomArray Inc. also uses 
CMOS in their DNA synthesis chips where photolithographic post-processing is required to form the 
electrode array [109]. Bionas use CMOS ICs in a 96-well plate format [110]. This seems to represent 
the first commercial product using CMOS in such a format and is an indication of what it likely to 
become  a  considerable  focus  for  this  technology  in  the  future.  However,  the  Bionas  ICs  require 
considerable photolithographic custom-/post-processing steps to integrate the various type of sensor 
(pH, oxygen consumption and cell-substrate impedance). 
6. CMOS Packaging Technology 
A  biosensor  generally  requires  some  form  of  carrier  or  package  to  support  and  position  its 
transducer. However, a key requirement of most biosensors is that the active area of the transducer is 
exposed to the external environment. This is different from most other forms of IC where input is 
through the package external electrical connections (e.g., leads or solder bumps) and these form a seal 
between the internal device and the environment. IC sensors may, for example, measure temperature, 
pressure, acceleration or light intensity (e.g., a photodiode or camera array) but these ICs can usually 
be sealed from their external environment (e.g., using a transparent window for light sensors) [111]. 
The micro-electromechanical systems (MEMS) market initially leveraged the semiconductor industry 
for both substrate and packaging technology, but the specific requirements of MEMS applications 
have more recently driven the design of new specialised package types [112]. Table 2 summarises 
some  of  the  challenges  and  illustrates  why  the  biosensor  market  struggles  to  utilise  high-volume 
semiconductor assembly methods.  
However,  there  are  still  many  applications  where  suitable  solutions  are  sparse,  especially  for 
biosensors  integrating  MEMS-based  transducers  (‘Bio-MEMS’)  [114].  Applications  based  on 
semiconductor  ICs  are  such  an  example,  requiring  demanding  packaging  solutions  not  readily 
available  commercially.  For  instance,  a  cell-based  biosensor  with  an  IC  transducer  raises  unique 
difficulties  where  the  transducer  on  the  semiconductor  die  must  contact  cell  culture  media  but 
simultaneously  provide  biocompatible  electrical  and  chemical  isolation  from  the  bondpads  and 
bondwires at the edge of the die [115]. 
Flexible assembly processes can accommodate the bonding of multiple components, including die 
and discrete components onto a single substrate to a form multi-chip-module (MCM, [Figure 13(a)]). 
Similarly, components can be assembled into a single package resulting in a system-on-chip (SoC). 
Standard packages can be used as a basis for the encapsulation, such as ceramic dual-in-line pin (DIP), 
plastic  DIP  (PDIP),  QFN,  QFP,  SOIC  and  SSOP  outlines  [116].  As  an  alternative  to  silicon,  
lower-scale integration is achievable on a range of flexible (polymer) or rigid (e.g., glass) substrates by 
depositing layers to form thin film transistors (TFTs). Sensors 2011, 11                                       
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Table 2. Summary of MEMS packaging requirements versus standard integrated circuit 
packaging (adapted from [113]). 
Bio-MEMS Applications  Standard Integrated Circuits  
Often involve moving solids or fluids  Stationary thin solid structures 
Require integration of microstructures with 
microelectronics 
No such integration is required 
Perform a variety or functions of 
biological, chemical, optical and 
electromechanical nature 
Transmit electrical signals only 
Many components are required to interface  
with working media and hostile environments 
Integrated circuit die are protected from working media by 
encapsulation 
Fewer electrical connections and leads  Large number of electrical connections and leads  
Lack of engineering design methodology 
and standards 
Well-established design methodology and standards 
Packaging technology is in its infancy  Mature packaging technology and clearly defined roadmaps 
Assembly is primarily manual  Highly automated assembly techniques available  
Lack of quality and reliability testing 
standards and test facilities  
Mature standards and established quality and reliable testing 
facilities 
Distinct manufacturing techniques for each 
application 
Manufacturing techniques are proven and well documented 
No industrial standards to follow in design, 
manufacture, packaging and testing 
Well-established methodologies and procedures 
 
Figure 13. Example packaging technologies frequently adapted for MEMS applications. 
(a) multi-chip-module, ‘system-on-chip’ (from [117]; scale bar is 5 mm); (b) open-cavity 
package, shown without die and bondwires (from [116]; scale bar is 1 mm). 
   
(a)  (b) 
With  the  industry  in  its  infancy,  several  prototyping  solutions  for  IC  biosensors  have  been 
developed by researchers to meet their specific needs [118-120], but presently there are no standards. 
Companies such as Sempac, U.S. [115] and Quik-Pak, U.S. [121] provide custom packaging solutions  
[Figure 13(b)] but these are based on semiconductor package outlines and are based on materials 
which may not be suitable for the biosensor applications (e.g., moulding compound biocompatibility, 
flexible substrates for use in vivo). Sensors 2011, 11                                       
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7. Obstacles to Commercialisation 
There are also generic barriers to commercialisation for all CMOS-based biosensor applications that 
are now discussed. Commercial transducers based on proprietary substrate technologies are not readily 
scaled to applications requiring a large numbers of electrodes, such as drug discovery and multiple 
electrode arrays for neuronal recordings. However, more scalable technologies such as CMOS have 
yet  to  demonstrate  reliable  operation  as  MEAs.  The  criteria  for  success  are  the  ability  to  culture 
neuronal cells on electrochemically and electronically stable CMOS electrodes, maintain cell health 
(vitality) through good biocompatibility and to demonstrate the recording of action potentials. 
Through continuous development of the CMOS interface, particular constraints and techniques are 
emerging  that  may  lead  to  successful  electrode  products.  These  are  summarised  in  Table  3.  The 
constraints  are  effectively  the  requirements  of  a  commercial  interface  whilst  the  emerging 
characteristics are defined as the techniques being pursued by a number of research groups. 
Table 3. Themes for commercially-viable CMOS neuronal interfaces. 
Constraints (for commercially-viable 
solutions) 
Emerging Characteristics 
use of standard CMOS technologies  
(mature processes: low cost; high availability)  
bondpad modification using plating 
high spatial resolution (for MEAs) using addressable sensor 
arrays 
no complex post-processing of ICs (e.g., no 
additional lithography) 
minimised cleft by using specific adhesion layer peptides 
useful lifetimes for long in vitro assays or 
long-term (chronic) implantation 
improved packaging based on MEMS technology 
robust signal amplification using very low-noise amplifier 
designs 
8. Conclusions, Outlook and Future Work 
IC technology is readily available as a biosensor transducer in its ubiquitous form as complementary 
metal oxide semiconductor (CMOS). However, to create a suitable interface to biological cells the 
transducer must include electrodes that are non-invasive and biocompatible—requirements that CMOS 
does  not  naturally  meet.  Researchers  have  therefore  modified  CMOS  ICs  by  applying  additional 
layers, but the only method proven to establish biocompatibility requires the use of microfabrication 
equipment in a semiconductor cleanroom. This is suitable for ICs manufactured for research purposes 
but, due to the high cost of this approach, the economies of scale provided by CMOS are lost. If 
CMOS-based biosensors are to be commercialised, then a low-cost method to modify the technology  
is required.  
Cell-based biosensor research has taken the first steps towards commercialisation but further work 
is needed to demonstrate CMOS technology in a commercial context. Firstly, packaging will remain an 
issue: either new methods will be required (e.g., microtitre plates with ICs in each well) or the partial 
encapsulation process will need refining. Considerable effort will be required in terms of ‘design for 
manufacture’ as the CMOS IC must be capable of supporting the post-processing (e.g., anodisation 
and  electrodeposition  processes)  which  must  integrate  with  other  IC  functional  blocks  such  as Sensors 2011, 11                                       
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amplifiers,  data  processing  and  communications  circuits.  Subsequently,  once  an  IC  design  and  
post-processing steps are finalised, the manufacturability (yield, process parameters) and reliability 
will need optimising. Industry-standard semiconductor reliability tests can be adopted for this purpose, 
supplemented by additional tests specific to biosensors such as biocompatibility testing. The process 
must also be future proof against fast moving semiconductor technology and it will be necessary for 
the post-processing methods to periodically transition to newer CMOS fabrication processes. From a 
commercial  viewpoint,  a  more  thorough  understanding  of  projected  production  costs  must  be 
performed and a business risk assessment made against competing technologies. For example, bench 
top processing of ICs seems intrinsically cost effective, but scaling to the high volumes of a production 
line has yet to undergo rigorous business analysis. In addition, if multiple ICs are to be integrated into 
the wells of microtitre plates, then acceptable production yield will need to be proven. 
The adoption of suitable IC post-processing may therefore foster the commercialisation of CMOS 
cell-based biosensors in drug discovery, neuroprosthetics, and environmental applications and enable 
affordable research tools for bioscience. 
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